ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,930.85
1.09%
US Tech 100
20,836.00
1.31%
Dow Jones
42,840.26
1.18%
Brent Oil
72.72
0.00%
Bitcoin
97,875.16
0.12%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Opko Health Inc (OPK)

  7. Opko Health Inc (OPK) News

OPK

Opko Health (OPK)

Opko Health Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OPK
DateTimeSourceHeadlineSymbolCompany
12/10/20248:00AMPR Newswire (US)NextPlat Gains e-Commerce Access to Over 340 Million Consumers with Launch on JD.Com, China's Largest Online RetailerNASDAQ:OPKOpko Health Inc
11/20/20249:36PMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:OPKOpko Health Inc
11/20/20248:00AMGlobeNewswire Inc.OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:OPKOpko Health Inc
11/18/20248:00AMPR Newswire (US)NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition ExpoNASDAQ:OPKOpko Health Inc
11/14/20246:00AMPR Newswire (US)NextPlat Reports $49.8 Million in Consolidated Revenue for the Nine Months Ended September 30, 2024, Representing a 136% Increase Over 2023 ResultsNASDAQ:OPKOpko Health Inc
11/13/20244:30PMEdgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:OPKOpko Health Inc
11/08/20245:23PMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:OPKOpko Health Inc
11/08/20244:05PMGlobeNewswire Inc.Entera Bio Reports Q3 2024 Financial Results and Provides Business UpdatesNASDAQ:OPKOpko Health Inc
11/07/20244:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPKOpko Health Inc
11/07/20244:05PMGlobeNewswire Inc.OPKO Health Reports Third Quarter 2024 Business Highlights and Financial ResultsNASDAQ:OPKOpko Health Inc
11/07/20248:00AMGlobeNewswire Inc.Aspira Women’s Health Expands Co-Marketing and Distribution Collaboration with BioReference® to Include OvaWatch®NASDAQ:OPKOpko Health Inc
10/29/20244:05PMGlobeNewswire Inc.OPKO Health to Report Third Quarter 2024 Financial Results on November 7, 2024NASDAQ:OPKOpko Health Inc
10/07/20248:00AMPR Newswire (US)NextPlat Secures Four-Year Extension of OPKO Healthcare E-Commerce Program in China and Agrees to the Expansion of the Program into JapanNASDAQ:OPKOpko Health Inc
10/07/20248:00AMGlobeNewswire Inc.ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza ProgramNASDAQ:OPKOpko Health Inc
09/25/20248:30AMGlobeNewswire Inc.Entera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide Tablet Candidate for Obesity and Metabolic DisordersNASDAQ:OPKOpko Health Inc
09/23/20248:00AMGlobeNewswire Inc.OPKO Health’s ModeX Therapeutics Appoints Dr. Giovanni Abbadessa as Chief Medical Officer as Pipeline Advances into Clinical DevelopmentNASDAQ:OPKOpko Health Inc
09/20/20242:56PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OPKOpko Health Inc
09/18/20244:13PMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:OPKOpko Health Inc
09/16/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPKOpko Health Inc
09/16/20247:30AMPR Newswire (US)Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO HealthNASDAQ:OPKOpko Health Inc
08/30/20245:01PMEdgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNASDAQ:OPKOpko Health Inc
08/23/20245:33PMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:OPKOpko Health Inc
08/19/20245:23PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPKOpko Health Inc
08/14/20244:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPKOpko Health Inc
08/12/20246:27PMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:OPKOpko Health Inc
08/09/20244:05PMGlobeNewswire Inc.Entera Bio Reports Q2 2024 Financial Results and Provides Business UpdatesNASDAQ:OPKOpko Health Inc
08/08/20245:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPKOpko Health Inc
08/07/20244:12PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OPKOpko Health Inc
08/07/20244:07PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPKOpko Health Inc
08/07/20244:06PMGlobeNewswire Inc.OPKO Health Reports Second Quarter 2024 Business Highlights and Financial ResultsNASDAQ:OPKOpko Health Inc
 Showing the most relevant articles for your search:NASDAQ:OPK

Your Recent History

USOTC
GRLT
Grillit (PK)
USOTC
RDAR
Raadr (PK)
USOTC
AFFU
Affluence (PK)
USOTC
MGON
Megola (PK)
USOTC
IFUS
Impact Fusion (PK)
NASDAQ
NXPL
NextPlat
USOTC
CBRF
CyberFuels (PK)
USOTC
PHIL
PHI (PK)
USOTC
GTCH
GBT Technologies (PK)
NASDAQ
ILLR
Triller
NYSE
IONQ
IonQ
USOTC
SPZI
Spooz (PK)
AMEX
KULR
KULR Technology
NASDAQ
AMRN
Amarin
COIN
SHIBUSD
SHIBA INU
USOTC
AXXA
Exxe (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads